163 related articles for article (PubMed ID: 18179747)
1. Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine.
Di Sciascio MB; Vianale G; Verna N; Petrarca C; Perrone A; Toniato E; Muraro R; Conti P; Di Gioacchino M
Int J Immunopathol Pharmacol; 2007; 20(4):745-51. PubMed ID: 18179747
[TBL] [Abstract][Full Text] [Related]
2. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
3. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.
Traidl-Hoffmann C; Münster I; Ring J; Behrendt H
Int Arch Allergy Immunol; 2006; 140(4):315-20. PubMed ID: 16741367
[TBL] [Abstract][Full Text] [Related]
4. The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: a placebo-controlled randomized study.
Cyr MM; Hayes LM; Crawford L; Baatjes AJ; Keith PK; Denburg JA
Int Arch Allergy Immunol; 2005 Nov; 138(3):209-16. PubMed ID: 16210859
[TBL] [Abstract][Full Text] [Related]
5. The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells.
Yamauchi Y; Fujikura T; Shimosawa T
Allergol Int; 2007 Jun; 56(2):171-7. PubMed ID: 17460445
[TBL] [Abstract][Full Text] [Related]
6. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.
Dizdar EA; Sekerel BE; Keskin O; Kalayci O; Adalioglu G; Dogan C; Tuncer A
Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):843-9. PubMed ID: 17346807
[TBL] [Abstract][Full Text] [Related]
7. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma.
Baena-Cagnani CE
Allergy; 2001; 56 Suppl 65():21-7. PubMed ID: 11243501
[TBL] [Abstract][Full Text] [Related]
8. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine: A new, nonsedating, oral antihistamine.
Geha RS; Meltzer EO
J Allergy Clin Immunol; 2001 Apr; 107(4):751-62. PubMed ID: 11295678
[TBL] [Abstract][Full Text] [Related]
10. [The place of new antihistamines in allergy management. Apropos of desloratadine].
Sabbah A
Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624
[TBL] [Abstract][Full Text] [Related]
11. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
Reinartz SM; Overbeek SE; Kleinjan A; van Drunen CM; Braunstahl GJ; Hoogsteden HC; Fokkens WJ
Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
13. Antihistamines: do they work? Further well-controlled trials involving larger samples are needed.
Fumagalli F; Baiardini I; Pasquali M; Compalati E; Guerra L; Massacane P; Canonica GW
Allergy; 2004 Aug; 59 Suppl 78():74-7. PubMed ID: 15245363
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide.
Lantero S; Sacco O; Scala C; Morelli MC; Rossi GA
Clin Exp Allergy; 1996 Jun; 26(6):656-64. PubMed ID: 8809423
[TBL] [Abstract][Full Text] [Related]
15. [The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma].
Kupczyk M; Bogacka E; Bocheńska-Marciniak M; Sterchaluk-Grzyb E; Tworek D; Kuna P
Pol Merkur Lekarski; 2005 Feb; 18(104):129-32. PubMed ID: 17877115
[TBL] [Abstract][Full Text] [Related]
16. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266
[TBL] [Abstract][Full Text] [Related]
17. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis.
Bachert C
Allergy; 2001; 56 Suppl 65():14-20. PubMed ID: 11243500
[TBL] [Abstract][Full Text] [Related]
18. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
19. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
Tillie-Leblond I; Hammad H; Desurmont S; Pugin J; Wallaert B; Tonnel AB; Gosset P
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):586-92. PubMed ID: 10934091
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic points of intervention and clinical implications: role of desloratadine.
Bachert C
Allergy; 2002; 57 Suppl 75():13-8. PubMed ID: 12492724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
